{"Symbol": "AKAN", "AssetType": "Common Stock", "Name": "Akanda Corp", "Description": "Akanda Corporation. The company is headquartered in New Romney, the United Kingdom.", "CIK": "1888014", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "DRUG MANUFACTURERS - SPECIALTY & GENERIC", "Address": "100 KING ST. W, TORONTO, ON, CANADA, M5X 1G5", "OfficialSite": "https://www.akandacorp.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "1883800", "EBITDA": "-3678018", "PERatio": "0.0058", "PEGRatio": "None", "BookValue": "22.67", "DividendPerShare": "None", "DividendYield": "None", "EPS": "154.84", "RevenuePerShareTTM": "6.92", "ProfitMargin": "-2.663", "OperatingMarginTTM": "-4.438", "ReturnOnAssetsTTM": "-0.287", "ReturnOnEquityTTM": "-0.609", "RevenueTTM": "836660", "GrossProfitTTM": "208380", "DilutedEPSTTM": "154.84", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0.219", "AnalystTargetPrice": "None", "AnalystRatingStrongBuy": "-", "AnalystRatingBuy": "-", "AnalystRatingHold": "-", "AnalystRatingSell": "-", "AnalystRatingStrongSell": "-", "TrailingPE": "0.0058", "ForwardPE": "-", "PriceToSalesRatioTTM": "2.252", "PriceToBookRatio": "0.558", "EVToRevenue": "3.196", "EVToEBITDA": "-0.795", "Beta": "1.689", "52WeekHigh": "27.5", "52WeekLow": "0.838", "50DayMovingAverage": "2.38", "200DayMovingAverage": "12.93", "SharesOutstanding": "2101500", "SharesFloat": "144660", "PercentInsiders": "0.000", "PercentInstitutions": "2.271", "DividendDate": "None", "ExDividendDate": "None"}